Corlanor 7.5 mg Oral Tablet
RxNorm 1649495
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1649495 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Corlanor 7.5 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Corlanor 7.5 mg (as ivabradine HCl 8.085 mg) Oral Tablet
(Atom ID: 7239567)
PSNPrescribable
Prescribable Name (PSN):
Corlanor 7.5 mg Oral Tablet
(Atom ID: 7238295)
SBDPrescribable
Semantic Branded Drug (SBD):
Ivabradine 7.5 mg Oral Tablet [Corlanor]
(Atom ID: 7238294)
Patient Education
Ivabradine
Ivabradine is used to treat certain adults with heart failure (condition in which the heart is unable to pump enough blood to the other parts of the body) to decrease the risk that their condition will worsen and need to be treated in a hospital. It is also used to treat a certain type of heart failure in children 6 months of age and older due to cardiomyopathy (a condition in which the heart muscle becomes weakened and enlarged). Ivabradine is in a class of medications called hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers. It works by slowing the heart rate so the heart can pump more blood through the body each time it beats.
[Learn More]
* Please review the disclaimer below.